Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rifaximin for Minimal Hepatic Encephalopathy
NCT01069133Phase 2Completed
- Sponsor
- Richmond VA Medical Center
- Start
- Feb 2010
- Primary completion
- May 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of rifaximin in hepatic encephalopathy (HE), sponsored by Richmond VA Medical Center. Started Feb 2010; status: completed.
02
Drugs
rifaximin
03
Conditions
hepatic encephalopathy (HE)
Beyond the preview
Go deeper on NCT01069133.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01069133.